Vontobel Holding Ltd. Krystal Biotech, Inc. Transaction History

Vontobel Holding Ltd.

  • $27.3 Billion
  • Q4 2024

A detailed history of Vontobel Holding Ltd. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 2,984 shares of KRYS stock, worth $457,268. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,984
Previous 7,519 60.31%
Holding current value
$457,268
Previous $1.37 Million 65.84%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$156.64 - $199.61 $710,362 - $905,231
-4,535 Reduced 60.31%
2,984 $467,000
Q3 2024

Oct 15, 2024
SELL
$174.7 - $213.66 $39,132 - $47,859
-224 Reduced 2.89%
7,519 $1.37 Million
Q2 2024

Aug 13, 2024
SELL
$153.12 - $183.64 $124,333 - $149,115
-812 Reduced 9.49%
7,743 $1.42 Million
Q1 2024

May 10, 2024
SELL
$108.01 - $179.35 $14,905 - $24,750
-138 Reduced 1.59%
8,555 $1.52 Million
Q4 2023

Jun 03, 2024
SELL
$96.0 - $128.29 $3,936 - $5,259
-41 Reduced 0.47%
8,693 $1.08 Million
Q4 2023

Jan 29, 2024
SELL
$96.0 - $128.29 $3,936 - $5,259
-41 Reduced 0.47%
8,693 $1.08 Million
Q3 2023

Jun 03, 2024
SELL
$108.51 - $130.22 $74,654 - $89,591
-688 Reduced 7.3%
8,734 $1.01 Million
Q3 2023

Oct 10, 2023
SELL
$108.51 - $130.22 $74,654 - $89,591
-688 Reduced 7.3%
8,734 $1.01 Million
Q2 2023

Jun 03, 2024
SELL
$78.48 - $130.32 $273,345 - $453,904
-3,483 Reduced 26.99%
9,422 $1.11 Million
Q2 2023

Jul 24, 2023
SELL
$78.48 - $130.32 $273,345 - $453,904
-3,483 Reduced 26.99%
9,422 $1.11 Million
Q1 2023

Jun 03, 2024
BUY
$72.39 - $84.27 $314,896 - $366,574
4,350 Added 50.85%
12,905 $1.03 Million
Q1 2023

Apr 12, 2023
SELL
$72.39 - $84.27 $128,492 - $149,579
-1,775 Reduced 12.09%
12,905 $1.03 Million
Q4 2022

Feb 14, 2023
SELL
$63.14 - $79.9 $201,290 - $254,721
-3,188 Reduced 17.84%
14,680 $1.16 Million
Q3 2022

Nov 04, 2022
SELL
$64.85 - $82.4 $66,276 - $84,212
-1,022 Reduced 5.41%
17,868 $1.25 Million
Q2 2022

Jul 27, 2022
SELL
$48.93 - $73.47 $337,519 - $506,796
-6,898 Reduced 26.75%
18,890 $1.24 Million
Q1 2022

May 13, 2022
SELL
$51.99 - $72.11 $58,332 - $80,907
-1,122 Reduced 4.17%
25,788 $1.72 Million
Q4 2021

Feb 14, 2022
BUY
$39.81 - $88.24 $219,432 - $486,378
5,512 Added 25.76%
26,910 $1.88 Million
Q3 2021

Oct 29, 2021
SELL
$52.01 - $71.77 $142,975 - $197,295
-2,749 Reduced 11.38%
21,398 $1.12 Million
Q2 2021

Aug 06, 2021
SELL
$62.14 - $81.82 $966,277 - $1.27 Million
-15,550 Reduced 39.17%
24,147 $1.64 Million
Q1 2021

May 11, 2021
BUY
$59.42 - $85.46 $193,055 - $277,659
3,249 Added 8.91%
39,697 $3.06 Million
Q4 2020

Feb 12, 2021
BUY
$40.64 - $61.38 $1.48 Million - $2.24 Million
36,448 New
36,448 $2.19 Million

Others Institutions Holding KRYS

# of Institutions
302
Shares Held
24.5M
Call Options Held
444K
Put Options Held
325K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $3.93B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email